KKR takes minority stake in Malaysia's Avisena Healthcare
What's the deal? KKR has agreed to make a minority investment in Avisena HealthcareDealroom has a profile for this one. Try Dealroom →, a Malaysian private hospital operator, the two announced on September 4. The funds are managed by KKR, one of the world's largest alternative asset managers.
Who's Avisena? Founded in 1996, the company runs Avisena Specialist HospitalDealroom has a profile for this one. Try Dealroom → and Avisena Specialist Hospital 2 in Shah Alam, in Malaysia's Klang Valley. It has built its presence in the region over the past three decades.
What's the money for? The capital will fund Avisena's next growth phase, including expanded multi-specialty offerings at its flagship Shah Alam hospitals and new greenfield hospitals across the Klang Valley.
The expansion angle: The greenfield build-out targets urban areas where capacity is lagging. Malaysia's private healthcare market is seeing growing demand, particularly in cities.
Why KKR? The firm has invested more than $20 billion across global healthcare since 2004. Its Asia Pacific portfolio already includes Medical Saigon GroupDealroom has a profile for this one. Try Dealroom → in Vietnam and Metro Pacific Hospital Holdings in the Philippines, plus healthcare businesses in India, Japan, and China.
What they're saying: "Avisena has built a differentiated healthcare platform serving the community for over 30 years," said SJ Lim, managing director at KKR. Group chief executive officer Elina Nadia Omar said KKR's "regional healthcare expertise" would help "expand our capabilities, strengthen our clinical offering, and deliver high-quality care to more patients."
What's next? The deal is subject to customary closing conditions. In Malaysia, KKR's prior investments have spanned OMS GroupDealroom has a profile for this one. Try Dealroom →, Weststar AviationDealroom has a profile for this one. Try Dealroom →, and Taylor's SchoolsDealroom has a profile for this one. Try Dealroom →.
The signal: KKR's backing marks Avisena's first institutional investor and reflects deepening private capital interest in Southeast Asian healthcare, where urban demand is outrunning hospital supply.
Image credit: ell brown
